Tech Company Financing Transactions
Emerald Therapeutics Funding Round
On 7/1/2014, Emerald Therapeutics raised Series B funding from Founders Fund, private investors and Schooner Capital.
Transaction Overview
Company Name
Announced On
7/1/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Founders Fund (Lead Investor) (Brian Singerman)
private investors (Lead Investor) (Max Levchin)
Proceeds Purpose
The company also announced the release of its first product: the Emerald Cloud Laboratory (ECL). The ECL is a state-of-the-art life sciences laboratory that scientists can remotely access via the Internet where automated robotics conduct experiments exactly as specified by the user.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
844 Dubuque Ave.
Menlo Park, CA 94080
USA
Menlo Park, CA 94080
USA
Phone
Website
Email Address
Overview
Emerald Cloud Laboratory (ECL) comes from Emerald Therapeutics, our venture-backed biotechnology company based in South San Francisco, California. Emerald was founded by two life-long friends (both Ph.D. scientists) and is staffed by top scientists and engineers from around the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Frezza
Browse more venture capital transactions:
Prev: 7/1/2014: IlluminOss Medical venture capital transaction
Next: 7/1/2014: Motiv Power Systems venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs